Multipl Sklerozda Hastalık Modifiye Edici Tedaviler: Genel Tedavi Prensipleri
Özet
Referanslar
Angelo Ghezzi Old and New Strategies in the Treatment of Pediatric Multiple Sclerosis: A Personal View for a New Treatment Approac Neurol Ther 2024 Aug;13(4):949-963. doi: 10.1007/s40120-024-00633-6. Epub 2024 Jun 1.
Padilha IG, Fonseca APA, Pettengill ALM, Fragoso DC, Pacheco FT, Nunes RH, Maia ACM Jr, da Rocha AJ. Pediatric multiple sclerosis: from clinical basis to imaging spectrum and differential diagnosis. Pediatr Radiol. 2020 May;50(6):776-792. doi: 10.1007/s00247-019-04582-3. Epub 2020 Jan 10.PMID: 31925460 Review.
Katarzyna Śladowska, Paweł Moćko, Tomasz Brzostek, Paweł Kawalec. Efficacy and safety of disease-modifying therapies in pediatric-onset multiple sclerosis: A systematic review of clinical trials and observational studies Mult Scler Relat Disord. 2025 Jan 7:94:106263. doi: 10.1016/j.msard.2025.106263. Online ahead of print.
Mark S Freedman 1, Virginia Devonshire 2, Pierre Duquette 3, Paul S Giacomini 4, Fabrizio Giuliani 5, Michael C Levin 6, Xavier Montalban 7, Sarah A Morrow 8, Jiwon Oh 7, Dalia Rotstein 7, E Ann Yeh 9; Canadian MS Working Group Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations Can J Neurol Sci. 2020 Jul;47(4):437-455. doi: 10.1017/cjn.2020.66. Epub 2020 Apr 6.
International Pediatric Multiple Sclerosis Study Group. Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis. Mult Scler. 2012 Jan;18(1):116-27
Sormani MP, Gasperini C, Romeo M, et al.; MAGNIMS study group. Assessing response to İnterferon-β in a multicenter dataset of patients with MS. Neurology 2016; 87: 134–140.
Sormani MP, Rio J, Tintorè M, et al. Scoring treatment response in patients with relapsing Multiple sclerosis. Mult Scler 2013; 19: 605–612.
Jamroz-Wis´niewska A, Zajdel R, Słowik A, et al. Modified rio score with platform therapy predicts treatment success with fingolimod and natalizumab in relapsing-remitting multiple sclerosis patients. J Clin Med 2021; 10: 1830.
Burton, J.M., et al., 2012. Oral versus intravenous steroids for treatment of relapses in Multiple Sclerosis. Cochrane Database Syst. Rev. 12, Cd006921.
Habek, M., et al., 2010. Treatment of steroid unresponsive relapse with plasma exchange in aggressive Multiple Sclerosis. Ther. Apher. Dial. 14 (3), 298–302.
Magana, S.M., et al., 2011. Beneficial plasma exchange response in central nervous system inflammatory demyelination. Arch. Neurol. 68 (7), 870–878.
Tselis, A., et al., 2008. Treatment of corticosteroid refractory optic neuritis in Multiple Sclerosis patients with intravenous immunoglobulin. Eur. J. Neurol. 15 (11), 1163–1167.
